FBInvestor
Stocks / Vivos Therapeutics Inc
Institutional Ownership

Vivos Therapeutics Inc

CUSIP 92859E207COM NEWVVOSQ1 2026

13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
24
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

9 filings · latest Jul 14, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jul 14, 2025Dawei Luo13G8.5%445.21BSEC
2Jun 16, 2025V-Co Investors LLC13D19.9%SEC
3Dec 30, 2024Mitchell P. Kopin13G5.0%297.3KSEC
4Dec 20, 2024V-Co Investors LLC13G9.9%SEC
5Nov 14, 2024Ionic Ventures, LLC13G/A1.8%83.0KSEC
6Nov 14, 2024Armistice Capital, LLC13G/A5.0%250.3KSEC
7Sep 24, 2024Ionic Ventures, LLC13G8.7%412.1KSEC
8Feb 14, 2024Huntsman Ronald Kirk13G/A3.2%69.6KSEC
9Feb 14, 2024Armistice Capital, LLC13G10.0%175.1KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →